{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Adult&page=29", "query": { "condition": "Adult", "page": 29 }, "page_size": 10 }, "pagination": { "page": 29, "page_size": 10, "total_count": 18635, "total_pages": 1864, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Adult&page=30&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Adult&page=28&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-23T17:39:12.170Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT06274723", "title": "Responses to E-cigarette Message Source and Presentation", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Vaping" ], "interventions": [ { "name": "Expert, one-sided", "type": "OTHER" }, { "name": "Expert, two-sided", "type": "OTHER" }, { "name": "Peer, one-sided", "type": "OTHER" }, { "name": "Peer, two-sided", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of Massachusetts, Worcester", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "24 Years", "sex": "ALL", "summary": "18 Years to 24 Years" }, "enrollment_count": 848, "start_date": "2024-11-05", "completion_date": "2024-12-17", "has_results": true, "last_update_posted_date": "2026-01-14", "last_synced_at": "2026-10-23T17:39:12.170Z", "location_count": 1, "location_summary": "Worcester, Massachusetts", "locations": [ { "city": "Worcester", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT06274723" }, { "nct_id": "NCT07859280", "title": "Supplementation of Cholecalciferol and Related Active Metabolites Through Bioenhancing Layer's Eggs", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Healthy Adult Participants", "Vitamin D Insufficiency" ], "interventions": [ { "name": "Vitamin D3 bioenhanced eggs", "type": "DIETARY_SUPPLEMENT" }, { "name": "25(OH)D3 bioenhanced eggs", "type": "DIETARY_SUPPLEMENT" } ], "intervention_types": [ "DIETARY_SUPPLEMENT" ], "sponsor": "Cornell University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "40 Years", "sex": "ALL", "summary": "18 Years to 40 Years" }, "enrollment_count": 60, "start_date": "2027-01", "completion_date": "2029-12", "has_results": false, "last_update_posted_date": "2026-10-05", "last_synced_at": "2026-10-23T17:39:12.170Z", "location_count": 1, "location_summary": "Ithaca, New York", "locations": [ { "city": "Ithaca", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT07859280" }, { "nct_id": "NCT00028496", "title": "Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Adenocarcinoma of the Colon", "Adenocarcinoma of the Gallbladder", "Adenocarcinoma of the Pancreas", "Adenocarcinoma of the Rectum", "Adult Primary Hepatocellular Carcinoma", "Advanced Adult Primary Liver Cancer", "Cholangiocarcinoma of the Gallbladder", "Diffuse Adenocarcinoma of the Stomach", "Intestinal Adenocarcinoma of the Stomach", "Male Breast Cancer", "Mixed Adenocarcinoma of the Stomach", "Ovarian Endometrioid Adenocarcinoma", "Paget Disease of the Breast With Intraductal Carcinoma", "Paget Disease of the Breast With Invasive Ductal Carcinoma", "Recurrent Adult Primary Liver Cancer", "Recurrent Breast Cancer", "Recurrent Colon Cancer", "Recurrent Gallbladder Cancer", "Recurrent Gastric Cancer", "Recurrent Malignant Testicular Germ Cell Tumor", "Recurrent Pancreatic Cancer", "Recurrent Rectal Cancer", "Recurrent Salivary Gland Cancer", "Salivary Gland Adenocarcinoma", "Stage II Malignant Testicular Germ Cell Tumor", "Stage II Pancreatic Cancer", "Stage III Colon Cancer", "Stage III Gastric Cancer", "Stage III Malignant Testicular Germ Cell Tumor", "Stage III Pancreatic Cancer", "Stage III Rectal Cancer", "Stage III Salivary Gland Cancer", "Stage IIIA Breast Cancer", "Stage IIIB Breast Cancer", "Stage IV Breast Cancer", "Stage IV Colon Cancer", "Stage IV Gastric Cancer", "Stage IV Pancreatic Cancer", "Stage IV Rectal Cancer", "Stage IV Salivary Gland Cancer", "Thyroid Gland Medullary Carcinoma", "Unresectable Gallbladder Cancer" ], "interventions": [ { "name": "recombinant fowlpox-CEA(6D)/TRICOM vaccine", "type": "BIOLOGICAL" }, { "name": "sargramostim", "type": "BIOLOGICAL" }, { "name": "recombinant fowlpox GM-CSF vaccine adjuvant", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 48, "start_date": "2001-11", "completion_date": null, "has_results": false, "last_update_posted_date": "2013-01-25", "last_synced_at": "2026-10-23T17:39:12.170Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT00028496" }, { "nct_id": "NCT02829996", "title": "Study of Fixed-Dose Combinations of Trabodenoson and Latanoprost in Adults With OHT or POAG", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Primary Open-Angle Glaucoma (POAG)", "Ocular Hypertension (OHT)" ], "interventions": [ { "name": "trabodenoson 6.0% / latanoprost 0.005% QD", "type": "DRUG" }, { "name": "trabodenoson 3.0% / latanoprost 0.005% QD", "type": "DRUG" }, { "name": "trabodenoson 6.0% / latanoprost 0.0025% QD", "type": "DRUG" }, { "name": "latanoprost 0.005% QD", "type": "DRUG" }, { "name": "latanoprost 0.0025% QD", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Inotek Pharmaceuticals Corporation", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 201, "start_date": "2016-08-19", "completion_date": "2017-05-31", "has_results": true, "last_update_posted_date": "2018-02-15", "last_synced_at": "2026-10-23T17:39:12.170Z", "location_count": 1, "location_summary": "Lexington, Massachusetts", "locations": [ { "city": "Lexington", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT02829996" }, { "nct_id": "NCT04236388", "title": "Short Term Ketone Supplementation and Cardiometabolic Health", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Cardiovascular Risk Factor" ], "interventions": [ { "name": "Ketone drink", "type": "DIETARY_SUPPLEMENT" }, { "name": "Placebo drink", "type": "DIETARY_SUPPLEMENT" } ], "intervention_types": [ "DIETARY_SUPPLEMENT" ], "sponsor": "Virginia Polytechnic Institute and State University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "50 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "50 Years to 75 Years" }, "enrollment_count": 11, "start_date": "2020-10-02", "completion_date": "2022-05-25", "has_results": false, "last_update_posted_date": "2026-03-27", "last_synced_at": "2026-10-23T17:39:12.170Z", "location_count": 1, "location_summary": "Blacksburg, Virginia", "locations": [ { "city": "Blacksburg", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT04236388" }, { "nct_id": "NCT00860223", "title": "Study Evaluating The Potential Effect Of Multiple Doses Of Neratinib On The Pharmacokinetics Of A Single Dose Of Digoxin", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "Digoxin", "type": "DRUG" }, { "name": "Neratinib", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Puma Biotechnology, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "ALL", "summary": "18 Years to 50 Years" }, "enrollment_count": 27, "start_date": "2009-04", "completion_date": "2009-04", "has_results": false, "last_update_posted_date": "2012-05-14", "last_synced_at": "2026-10-23T17:39:12.170Z", "location_count": 1, "location_summary": "Miami, Florida", "locations": [ { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00860223" }, { "nct_id": "NCT06204679", "title": "Pharmacokinetics of Fixed-Dose Combination Tablet of Bemnifosbuvir and Ruzasvir", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Volunteer Study" ], "interventions": [ { "name": "Bemnifosbuvir (BEM)/Ruzasvir (RZR) FDC under fasting conditions", "type": "DRUG" }, { "name": "Bemnifosbuvir (BEM)/Ruzasvir (RZR) FDC under fed conditions", "type": "DRUG" }, { "name": "Bemnifosbuvir (BEM) and Ruzasvir (RZR) as reference formulation under fasting conditions", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Atea Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 42, "start_date": "2023-12-14", "completion_date": "2024-08-25", "has_results": false, "last_update_posted_date": "2024-09-19", "last_synced_at": "2026-10-23T17:39:12.170Z", "location_count": 1, "location_summary": "Cypress, California", "locations": [ { "city": "Cypress", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06204679" }, { "nct_id": "NCT03932903", "title": "Mobile Health Intervention to Support Oral Chemotherapy Adherence in Adolescents and Young Adults With Leukemia", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Acute Lymphoblastic Leukemia", "Lymphoblastic Lymphoma" ], "interventions": [ { "name": "ADAPTS (ADherence Assessments and Personalized Timely Support).", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Northwestern University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "14 Years", "maximum_age": null, "sex": "ALL", "summary": "14 Years and older" }, "enrollment_count": 60, "start_date": "2025-07-31", "completion_date": "2027-08-31", "has_results": false, "last_update_posted_date": "2026-06-30", "last_synced_at": "2026-10-23T17:39:12.170Z", "location_count": 1, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT03932903" }, { "nct_id": "NCT05780983", "title": "Sleep Well 24 (SWELL24) Healthy Sleep-Wake Behaviors in Older Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Insomnia Disorder" ], "interventions": [ { "name": "education and coaching on developing healthy nighttime sleep and daytime activity behaviors", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Wake Forest University Health Sciences", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "65 Years", "maximum_age": null, "sex": "ALL", "summary": "65 Years and older" }, "enrollment_count": 7, "start_date": "2024-05-08", "completion_date": "2024-10-28", "has_results": true, "last_update_posted_date": "2025-10-30", "last_synced_at": "2026-10-23T17:39:12.170Z", "location_count": 1, "location_summary": "Winston-Salem, North Carolina", "locations": [ { "city": "Winston-Salem", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT05780983" }, { "nct_id": "NCT00893360", "title": "CArdiosphere-Derived aUtologous Stem CElls to Reverse ventricUlar dySfunction", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Recent Myocardial Infarction", "Ventricular Dysfunction" ], "interventions": [ { "name": "Autologous stem cell infusion", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Cedars-Sinai Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 31, "start_date": "2009-05", "completion_date": "2012-02", "has_results": false, "last_update_posted_date": "2014-02-12", "last_synced_at": "2026-10-23T17:39:12.170Z", "location_count": 2, "location_summary": "Los Angeles, California • Baltimore, Maryland", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00893360" } ] }